Microsoft Teams meeting

Join on your computer or mobile app

Click here to join the meeting

Or call in (audio only)

+1 469-208-1641,,833710870#   United States, Dallas

Phone Conference ID: 833 710 870#

Find a local number | Reset PIN

Learn More | Meeting options

OBJECTIVES: Upon completion of this activity, the participant should be able to:

1.  Describe the clinical impact of surfactant therapy.

2.  Discuss the changes in indications for surfactant therapy in the context of less invasive respiratory support.

3.  Appraise and gain insight into new potential delivery methods and surfactant formulations.

FACULTY DISCLOSURE:  Dr. Roger Soll receives a salary as the Vice President at the Vermont Oxford Network.

All relevant financial relationships have been mitigated.

PLANNER DISCLOSURE: Niraj Vora, MD and Govande Vinayak, MD, have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC PART 2:  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For information, please contact Irene Guillen at [email protected]